124 related articles for article (PubMed ID: 6976503)
1. The [125I]C1q binding assay for the detection of soluble immune complexes.
Zubler RH; Carpentier N; Lambert PH
Methods Enzymol; 1981; 74 Pt C():530-7. PubMed ID: 6976503
[No Abstract] [Full Text] [Related]
2. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
3. [Clq binding activity of monomeric IgG].
Uwatoko S; Aotsuka S; Okawa M; Yokohari R; Aizawa C; Suzuki K
Arerugi; 1982 Oct; 31(10):1022-8. PubMed ID: 6984822
[No Abstract] [Full Text] [Related]
4. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
5. Rapid three-step purification procedure for isolation of the C1q component of human complement and its use in a solid-phase C1q binding assay.
Bähr EA; Drahovsky D
J Immunol Methods; 1984 Apr; 69(1):43-50. PubMed ID: 6325543
[TBL] [Abstract][Full Text] [Related]
6. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
7. [Detection of circulating immune complexes by enzyme immunoassay. A basic study of C1q enzyme immunoassay and anti-C3 enzyme immunoassay using microplates].
Yokoyama K
Arerugi; 1984 Feb; 33(2):117-26. PubMed ID: 6380453
[No Abstract] [Full Text] [Related]
8. Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).
Glikmann G; Svehag SE
Methods Enzymol; 1981; 74 Pt C():571-88. PubMed ID: 6798369
[No Abstract] [Full Text] [Related]
9. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
Narumoto J
Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
[TBL] [Abstract][Full Text] [Related]
10. The interference of fibrinogen and heparin with the determination of circulating immune complexes in the C1q-binding assay.
Faaber P; Capel PJ; Koene RA
Clin Exp Immunol; 1981 Sep; 45(3):590-4. PubMed ID: 6978209
[TBL] [Abstract][Full Text] [Related]
11. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
[TBL] [Abstract][Full Text] [Related]
12. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
Fiocco GP; Davis JS; Burge JJ
Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
[No Abstract] [Full Text] [Related]
13. An extended C1q-binding assay using lactoperoxidase- and chloramine-T-iodinated C1q. Immediate distinction between immune-aggregate-mediated and non-immune-aggregate-mediated C1q binding.
Spaeth PJ; Corvetta A; Nydegger UE; Montroni M; Buetler R
Scand J Immunol; 1983 Oct; 18(4):319-28. PubMed ID: 6606219
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in cervical cancer patients as detected by C1q binding.
Chao KC; Liu CC; Ng HT; Hu CP; Chang CM
Proc Natl Sci Counc Repub China B; 1984 Jan; 8(1):50-3. PubMed ID: 6335756
[TBL] [Abstract][Full Text] [Related]
15. Association between circulating immune complexes and renal disease in New Zealand mice.
Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
[TBL] [Abstract][Full Text] [Related]
16. Problems in the detection of complement-fixing immune complexes.
Rødahl E
Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in rheumatic fever.
Kawakami K; Hokonohara M; Miyata K; Terawaki T
Jpn Circ J; 1982 Nov; 46(11):1188-91. PubMed ID: 6982348
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
[TBL] [Abstract][Full Text] [Related]
19. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
Belozerov AP
Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the recommended use of anti-Clq for reducing non-specific reactions in solid-phase C1q assays for circulating immune complexes.
Wainer EM; Schepers G; Schweizer K; Pusztai-Markos Z
J Immunol Methods; 1984 Jan; 66(1):193-5. PubMed ID: 6363550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
